Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Palo Alto, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Semnur Pharmaceuticals, Inc. has filed 210 SEC EDGAR filings since 01 Mar 2022

SEC filing history

Showing 126-150 of 210 matching filings.

Per page
25
Current page
6
10-Q File 001-41351

QUARTERLY REPORT

Filing date
22 May 2024
Reporting date
31 Mar 2024
Next action
Verify source filing
NT 10-Q File 001-41351

NOTIFICATION OF LATE FILING

Filing date
15 May 2024
Reporting date
31 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-41351

ANNUAL REPORT

Filing date
01 Apr 2024
Reporting date
31 Dec 2023
Next action
Verify source filing
8-K File 001-41351

CURRENT REPORT

Filing date
27 Feb 2024
Reporting date
22 Feb 2024
Next action
Verify source filing
SC 13G/A File 005-93795

SC 13G/A filing

Filing date
22 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-93795

SC 13G filing

Filing date
14 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-93795

SC 13G

Filing date
14 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-93795

SC 13G/A filing

Filing date
13 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-93795

SC 13G/A filing

Filing date
13 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-93795

DENALI CAPITAL ACQUISITION CORP

Filing date
13 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-93795

DECA 13G/A

Filing date
02 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-41351

CURRENT REPORT

Filing date
10 Jan 2024
Reporting date
09 Jan 2024
Next action
Verify source filing
425 File 001-41351

FORM 425

Filing date
29 Dec 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-41351

DEFINITIVE ADDITIONAL MATERIALS

Filing date
29 Dec 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
425 File 001-41351

CURRENT REPORT

Filing date
29 Dec 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-41351

CURRENT REPORT

Filing date
29 Dec 2023
Reporting date
29 Dec 2023
Next action
Verify source filing
DEFM14A File 001-41351

DEFM14A

Filing date
15 Dec 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
425 File 001-41351

CURRENT REPORT

Filing date
20 Nov 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-41351

CURRENT REPORT

Filing date
20 Nov 2023
Reporting date
17 Nov 2023
Next action
Verify source filing
10-Q File 001-41351

QUARTERLY REPORT

Filing date
09 Nov 2023
Reporting date
30 Sep 2023
Next action
Verify source filing
SC 13G File 005-93795

SC 13G filing

Filing date
07 Nov 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
425 File 001-41351

CURRENT REPORT

Filing date
11 Oct 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-41351

CURRENT REPORT

Filing date
11 Oct 2023
Reporting date
11 Oct 2023
Next action
Verify source filing
DEFR14A File 001-41351

PROXY STATEMENT

Filing date
28 Sep 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-41351

PROXY STATEMENT

Filing date
25 Sep 2023
Reporting date
11 Oct 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .